Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Jardiance and Its Alleged Connection to Fournier’s Gangrene

FDA Warning 

In August 2018, the FDA issued a warning regarding a possible link between SGLT2 inhibitors and Fournier’s gangrene. The warning came after the FDA’s analysis of events from 2013-2018 found several cases of Fournier’s gangrene in patients receiving SGLT2 inhibitors, including Jardiance. This warning served as the initial trigger for various legal actions against the manufacturers of these drugs, including Boehringer Ingelheim and Eli Lilly. [1]

Legal Actions and Lawsuits 

Several lawsuits were filed after the FDA warning, primarily focusing on the manufacturers’ alleged failure to properly warn patients and their physicians about the risk of Fournier’s gangrene. Plaintiffs argue that they were not informed about the potential risks and, therefore, could not make a well-informed decision about their treatment. [2]

Latest in the Litigation 

As of recent updates, the litigation process is ongoing. Both sides present robust arguments. The defendants maintain that they had adequately communicated all potential risks through their product labeling and deny any negligence in this matter. [3]

 On the other hand, plaintiffs insist that the potential risk of developing Fournier’s gangrene was not sufficiently explained, arguing that, had they been aware of these risks, they might have opted for alternative treatments. Courts have yet not reached a definitive conclusion. This case can potentially prompt further scrutiny regarding the responsibility of pharma companies in providing comprehensive safety data on their drugs and may set precedence for laws regulating drug safety information disclosure. [3]

If you or a loved one has suffered an injury from Jardiance, give us a call at the Michael Brady Lynch Firm at 888-585-5970 or brandon@mblynchfirm.com. 

Date: August 15, 2023

Author: Brandon Salter

Citations

[1] https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrences-serious-infection-genital-area-sglt2-inhibitors-diabetes

[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450557/

[3] https://www.drugs.com/medical-answers/jardiance-perineum-3552698/#:~:text=Jardiance%20has%20a%20rare%20side,anus%20and%20vulva%20in%20women

Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
Cruise Ship Sexual Assault Prevention

Cruise Ship Sexual Assault Prevention

The cruising industry is booming, with new cruise ships being built and sailing away from Florida ports each year. While cruising is a relatively safe vacation, unfortunately, things don’t always go as planned. Crimes happen on cruise ships, just as they do anywhere else. Sexual assault is the most common crime reported on cruise ships. In 2023, there were 131 reports of sexual assault and rape on cruise ships.

read more
The Dangers of Suboxone and Emerging Lawsuits

The Dangers of Suboxone and Emerging Lawsuits

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
Cruise Ship Sex Assaults

Cruise Ship Sex Assaults

Sexual abuse and assault aboard cruise ships is a pressing issue that continues to plague the cruise industry, raising concerns about the safety and security of passengers and crew members on these vessels. Despite many viewing cruises as idyllic getaways, the unfortunate reality is that incidents of sexual violence can and do happen, often with complications due to the international waters and jurisdictions in which these ships operate.

read more
Mental Health Concerns Prompt Social Media Lawsuits

Mental Health Concerns Prompt Social Media Lawsuits

Reports indicate that 90% of teens ages 13 to 17 are active on social media and spend upwards of nine hours on the internet a day. Although modern technology has many benefits to offer our society, research indicates that excessive social media use negatively affects the mental health of teenagers and young adults

read more
The Talcum Powder Lawsuit – A Legal Overview

The Talcum Powder Lawsuit – A Legal Overview

In recent years, a significant number of lawsuits have been filed against companies manufacturing talcum powder-based products, alleging that long-term use has led to health complications, particularly ovarian cancer and mesothelioma.

read more
×
What Our Clients Are Saying